Phytopharm Reports Preclinical ALS Success

British company Phytopharm reports that new research shows that its neurotrophic drug Cogane leads to significant improvement in muscle strength in ALS mice in studies conducted by an academic collaborator. Cogane is currently in clinical trials for Parkinson’s disease and has received orphan drug status for ALS by the American and European regulatory agencies.

Click here to read more.

Share this:
Facebooktwittergoogle_plusmailFacebooktwittergoogle_plusmail